World Conference on Lung Cancer 2021 Highlights

IASLC Webinars
Overview

Join Drs. Harpole, Higgins, and Stinchcombe as they discuss the latest developments presented during the scientific and educational program at 2021 World Conference on Lung Cancer Worldwide Virtual Event. The webinar will consist of three 15 minute presentations followed by a 15 minute time for question and answers.

Date
Oct 01, 2021 -
Oct 01, 2021
CME Accredited

Friday, October 1, 2021 

2 PM MDT 

4 PM EDT 

At the conclusion of this activity, participants will be able to:

  1. Describe scientific progress in the prevention, early detection, diagnosis and treatment of thoracic malignancies.
  2. Explain advances in the multidisciplinary management of patients in relation to current standards of care.
  3. Identify the most relevant clinical research results and ongoing trials likely to impact patient care in the near future.

This webinar is designed to meet the educational needs of physicians, nurses and allied health professionals, pharmacists, patient advocates, and researchers who specialize in diagnostic radiology, hematology, pulmonary medicine, palliative care, medical oncology, thoracic surgery, and radiation oncology. 

Accreditation Statement

The International Association for the Study of Lung Cancer is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

The International Association for the Study of Lung Cancer designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Dr. Kristin Higgins  

  • Nothing to Disclose 

Dr. David Harpole 

  • Scientific Advisory Board: AstraZeneca, Medtronic, Novartis
  • Steering Committee: AEGEAN

Dr. Thomas Stinchcombe 

  • Advisory Board (ended): Takeda, AstraZeneca, Genentech/Roche, Foundation Medicine, Pfizer, EMD Serono, Novartis, Daiichi Sankyo, Lilly, Medtronic, Puma Biotechnology, Janssen Oncology, Regeneron
  • Research funding from ineligible companies: Genentech/Roche, Blueprint Medicines, AstraZeneca, Takeda, Advaxis, Regeneron (institution)

Friday, October 1, 2021 

2 PM MDT 

4 PM EDT 

At the conclusion of this activity, participants will be able to:

  1. Describe scientific progress in the prevention, early detection, diagnosis and treatment of thoracic malignancies.
  2. Explain advances in the multidisciplinary management of patients in relation to current standards of care.
  3. Identify the most relevant clinical research results and ongoing trials likely to impact patient care in the near future.

This webinar is designed to meet the educational needs of physicians, nurses and allied health professionals, pharmacists, patient advocates, and researchers who specialize in diagnostic radiology, hematology, pulmonary medicine, palliative care, medical oncology, thoracic surgery, and radiation oncology. 

Accreditation Statement

The International Association for the Study of Lung Cancer is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

The International Association for the Study of Lung Cancer designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Dr. Kristin Higgins  

  • Nothing to Disclose 

Dr. David Harpole 

  • Scientific Advisory Board: AstraZeneca, Medtronic, Novartis
  • Steering Committee: AEGEAN

Dr. Thomas Stinchcombe 

  • Advisory Board (ended): Takeda, AstraZeneca, Genentech/Roche, Foundation Medicine, Pfizer, EMD Serono, Novartis, Daiichi Sankyo, Lilly, Medtronic, Puma Biotechnology, Janssen Oncology, Regeneron
  • Research funding from ineligible companies: Genentech/Roche, Blueprint Medicines, AstraZeneca, Takeda, Advaxis, Regeneron (institution)

Share

Participants

David Harpole
David H. Harpole

MD

Thoracic Surgeon
Duke Cancer Center
Dr. Higgins
Kristin A. Higgins

MD

Associate Professor and Medical Director
Winship Cancer Institute of Emory University Department of Radiation Oncology
Thomas Stinchcombe
Thomas Stinchcombe

MD

Medical Oncologist
Duke Cancer Center